Publication Information

{'id': 'https://openalex.org/W2198268645', 'doi': 'https://doi.org/10.1158/1538-7445.am2015-1685', 'title': 'Abstract 1685: <i>In vivo</i> efficacy of PSMA ADC in combination with enzalutamide in castration-resistant prostate cancer', 'display_name': 'Abstract 1685: <i>In vivo</i> efficacy of PSMA ADC in combination with enzalutamide in castration-resistant prostate cancer', 'publication_year': 2015, 'publication_date': '2015-08-01', 'ids': {'openalex': 'https://openalex.org/W2198268645', 'doi': 'https://doi.org/10.1158/1538-7445.am2015-1685', 'mag': '2198268645'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2015-1685', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5017807897', 'display_name': 'Vincent A. DiPippo', 'orcid': 'https://orcid.org/0000-0002-5529-4195'}, 'institutions': [{'id': 'https://openalex.org/I4210116119', 'display_name': 'Progenics Pharmaceuticals (United States)', 'ror': 'https://ror.org/023ka9926', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210116119']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Vincent A. DiPippo', 'raw_affiliation_strings': ['1Progenics Pharmaceuticals, Inc., Tarrytown, NY;'], 'affiliations': [{'raw_affiliation_string': '1Progenics Pharmaceuticals, Inc., Tarrytown, NY;', 'institution_ids': ['https://openalex.org/I4210116119']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5002466627', 'display_name': 'Holly M. Nguyen', 'orcid': 'https://orcid.org/0000-0002-6331-8089'}, 'institutions': [{'id': 'https://openalex.org/I201448701', 'display_name': 'University of Washington', 'ror': 'https://ror.org/00cvxb145', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I201448701']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Holly M. Nguyen', 'raw_affiliation_strings': ['2University of Washington, Seattle, WA.'], 'affiliations': [{'raw_affiliation_string': '2University of Washington, Seattle, WA.', 'institution_ids': ['https://openalex.org/I201448701']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5088583553', 'display_name': 'Lisha G. Brown', 'orcid': 'https://orcid.org/0009-0009-7262-2080'}, 'institutions': [{'id': 'https://openalex.org/I201448701', 'display_name': 'University of Washington', 'ror': 'https://ror.org/00cvxb145', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I201448701']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Lisha G. Brown', 'raw_affiliation_strings': ['2University of Washington, Seattle, WA.'], 'affiliations': [{'raw_affiliation_string': '2University of Washington, Seattle, WA.', 'institution_ids': ['https://openalex.org/I201448701']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5017367178', 'display_name': 'William C. Olson', 'orcid': 'https://orcid.org/0000-0001-6254-0641'}, 'institutions': [{'id': 'https://openalex.org/I4210116119', 'display_name': 'Progenics Pharmaceuticals (United States)', 'ror': 'https://ror.org/023ka9926', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210116119']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'William C. Olson', 'raw_affiliation_strings': ['1Progenics Pharmaceuticals, Inc., Tarrytown, NY;'], 'affiliations': [{'raw_affiliation_string': '1Progenics Pharmaceuticals, Inc., Tarrytown, NY;', 'institution_ids': ['https://openalex.org/I4210116119']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5108554327', 'display_name': 'Robert L. Vessella', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I201448701', 'display_name': 'University of Washington', 'ror': 'https://ror.org/00cvxb145', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I201448701']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Robert L. Vessella', 'raw_affiliation_strings': ['2University of Washington, Seattle, WA.'], 'affiliations': [{'raw_affiliation_string': '2University of Washington, Seattle, WA.', 'institution_ids': ['https://openalex.org/I201448701']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5018745405', 'display_name': 'Eva Corey', 'orcid': 'https://orcid.org/0000-0002-9244-3807'}, 'institutions': [{'id': 'https://openalex.org/I201448701', 'display_name': 'University of Washington', 'ror': 'https://ror.org/00cvxb145', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I201448701']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Eva Corey', 'raw_affiliation_strings': ['2University of Washington, Seattle, WA.'], 'affiliations': [{'raw_affiliation_string': '2University of Washington, Seattle, WA.', 'institution_ids': ['https://openalex.org/I201448701']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 2, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.242, 'has_fulltext': False, 'cited_by_count': 3, 'citation_normalized_percentile': {'value': 0.679106, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 76, 'max': 79}, 'biblio': {'volume': '75', 'issue': '15_Supplement', 'first_page': '1685', 'last_page': '1685'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10543', 'display_name': 'Prostate Cancer Treatment and Research', 'score': 0.9991, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10543', 'display_name': 'Prostate Cancer Treatment and Research', 'score': 0.9991, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11395', 'display_name': 'Radiopharmaceutical Chemistry and Applications', 'score': 0.994, 'subfield': {'id': 'https://openalex.org/subfields/2741', 'display_name': 'Radiology, Nuclear Medicine and Imaging'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12465', 'display_name': 'Cancer, Lipids, and Metabolism', 'score': 0.9747, 'subfield': {'id': 'https://openalex.org/subfields/1306', 'display_name': 'Cancer Research'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/enzalutamide', 'display_name': 'Enzalutamide', 'score': 0.9106694}, {'id': 'https://openalex.org/keywords/glutamate-carboxypeptidase-ii', 'display_name': 'Glutamate carboxypeptidase II', 'score': 0.64922535}, {'id': 'https://openalex.org/keywords/antibody-drug-conjugate', 'display_name': 'Antibody-drug conjugate', 'score': 0.5057833}], 'concepts': [{'id': 'https://openalex.org/C2776551883', 'wikidata': 'https://www.wikidata.org/wiki/Q1996756', 'display_name': 'Enzalutamide', 'level': 5, 'score': 0.9106694}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.84308773}, {'id': 'https://openalex.org/C2780192828', 'wikidata': 'https://www.wikidata.org/wiki/Q181257', 'display_name': 'Prostate cancer', 'level': 3, 'score': 0.8338475}, {'id': 'https://openalex.org/C20417620', 'wikidata': 'https://www.wikidata.org/wiki/Q4140229', 'display_name': 'Glutamate carboxypeptidase II', 'level': 4, 'score': 0.64922535}, {'id': 'https://openalex.org/C2777325958', 'wikidata': 'https://www.wikidata.org/wiki/Q1069596', 'display_name': 'Antibody-drug conjugate', 'level': 4, 'score': 0.5057833}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.44602057}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.40805653}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.36123824}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.3394916}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.3375099}, {'id': 'https://openalex.org/C159654299', 'wikidata': 'https://www.wikidata.org/wiki/Q79460', 'display_name': 'Antibody', 'level': 2, 'score': 0.31486714}, {'id': 'https://openalex.org/C542903549', 'wikidata': 'https://www.wikidata.org/wiki/Q422248', 'display_name': 'Monoclonal antibody', 'level': 3, 'score': 0.1431196}, {'id': 'https://openalex.org/C203014093', 'wikidata': 'https://www.wikidata.org/wiki/Q101929', 'display_name': 'Immunology', 'level': 1, 'score': 0.11367631}, {'id': 'https://openalex.org/C61367390', 'wikidata': 'https://www.wikidata.org/wiki/Q416601', 'display_name': 'Androgen receptor', 'level': 4, 'score': 0.08099502}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2015-1685', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'score': 0.85, 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W3197069188', 'https://openalex.org/W3155718207', 'https://openalex.org/W3112221349', 'https://openalex.org/W3044054345', 'https://openalex.org/W3016632711', 'https://openalex.org/W3013460946', 'https://openalex.org/W2927728931', 'https://openalex.org/W2309274182', 'https://openalex.org/W2198268645', 'https://openalex.org/W1872007843'], 'abstract_inverted_index': {'Abstract': [0], 'Despite': [1], 'multiple': [2], 'new': [3, 30], 'treatment': [4, 71, 222, 255, 465], 'options': [5], 'for': [6, 69, 142, 195, 220, 455, 512], 'patients': [7], 'with': [8, 119, 152, 173, 223, 386, 391, 406, 463, 494], 'castration-resistant': [9, 497], 'prostate': [10, 85, 498], 'cancer': [11, 86], '(CRPC),': [12], 'the': [13, 70, 106, 112, 208, 233, 252, 256, 289, 296, 310, 328, 369, 374, 396, 407, 422, 432, 442, 504, 509], 'overall': [14], 'survival': [15, 356, 366], 'benefit': [16], 'still': [17], 'remains': [18], 'relatively': [19], 'short.': [20], 'Therefore,': [21], 'it': [22], 'is': [23, 63, 437], 'possible': [24], 'that': [25, 156, 318, 359, 421, 436], 'combining': [26], 'these': [27], 'and': [28, 42, 89, 98, 193, 205, 245, 277, 283, 298, 323, 355, 390], 'other': [29], 'agents': [31], 'can': [32], 'potentially': [33], 'broaden': [34], 'individual': [35], 'therapeutic': [36], 'windows': [37], 'by': [38, 344], 'achieving': [39], 'greater': [40], 'efficacy': [41, 79, 113, 488], 'improved': [43], 'safety': [44], 'profiles.': [45], 'Prostate-specific': [46], 'membrane': [47], 'antigen': [48], 'antibody-drug': [49], 'conjugate': [50], '(PSMA': [51], 'ADC),': [52], 'a': [53, 128, 134, 139, 148, 174, 187, 210, 351, 452], 'fully': [54], 'human': [55], 'anti-PSMA': [56], 'antibody': [57], 'linked': [58], 'to': [59, 110, 121, 137, 163, 197, 239], 'monomethylauristatin': [60], 'E': [61], '(MMAE),': [62], 'currently': [64], 'in': [65, 83, 101, 117, 127, 161, 258, 268, 285, 288, 309, 327, 346, 364, 378, 395, 431, 461, 492, 496], 'phase': [66], '2': [67], 'development': [68], 'of': [72, 80, 105, 114, 150, 177, 213, 232, 254, 264, 424, 445, 458, 489, 503, 508], 'CRPC.': [73], 'We': [74], 'have': [75, 91], 'previously': [76, 157], 'demonstrated': [77, 202], 'significant': [78, 159, 365, 400], 'PSMA': [81, 96, 115, 143, 154, 164, 178, 200, 214, 234, 240, 278, 311, 329, 381, 425, 459, 490], 'ADC': [82, 97, 116, 179, 190, 201, 215, 241, 279, 312, 330, 460, 491], 'advanced': [84], 'patient-derived': [87, 124], 'xenografts': [88, 125], 'moreover': [90], 'also': [92, 342], 'shown': [93], 'synergy': [94], 'between': [95], 'enzalutamide': [99, 495], '(ENZ)': [100], 'vitro.': [102], 'The': [103, 230, 337], 'objective': [104], 'current': [107], 'studies': [108], 'was': [109, 218, 341], 'evaluate': [111], 'combination': [118, 221, 236, 290, 370, 397, 408, 423, 462, 493], 'ENZ': [120, 224, 243, 273, 299, 332, 379], 'inhibit': [122], 'CRPC': [123, 151], '(PDX)': [126], 'preclinical': [129], 'setting.': [130], 'First,': [131], 'we': [132], 'performed': [133], 'pilot': [135], 'study': [136], 'determine': [138], 'sub-optimal': [140], 'dose': [141, 176, 212], 'ADC,': [144], 'using': [145], 'LuCaP': [146, 169, 433], '96CR,': [147], 'model': [149, 435], 'high': [153], 'expression': [155], 'showed': [158], 'regressions': [160], 'response': [162], 'ADC.': [165], 'Animals': [166], 'bearing': [167], 'subcutaneous': [168], '96CR': [170, 434], 'were': [171, 237, 303, 315, 373, 404], 'treated': [172], 'single': [175, 211], '(1,': [180], '2,': [181], 'or': [182, 186], '5': [183], 'mg/kg,': [184], 'IP)': [185], 'non-PSMA': [188], 'targeted': [189], '(5': [191], 'mg/kg)': [192, 217], 'followed': [194], 'up': [196, 354], '10': [198], 'weeks.': [199], 'dose-dependent': [203], 'efficacy,': [204], 'based': [206], 'on': [207], 'results,': [209], '(2': [216], 'selected': [219], '(50': [225], 'mg/kg;': [226], '5x/week,': [227], 'oral': [228], 'gavage).': [229], 'effects': [231, 372, 403, 444], 'ADC+ENZ': [235, 382, 426], 'compared': [238], 'alone,': [242, 244], 'placebo': [246], 'control.': [247], 'At': [248], 'six': [249], 'weeks': [250], 'after': [251], 'beginning': [253], 'changes': [257, 345], 'tumor': [259, 266, 286, 321, 338], 'volume': [260, 267, 287], 'were:': [261], 'fold': [262], 'increases': [263], 'enrollment': [265], 'control': [269, 297], '(4.9': [270], '±': [271, 275, 281, 293], '0.40);': [272], '(2.83': [274], '0.37);': [276], '(1.6': [280], '0.43);': [282], 'decrease': [284], 'group': [291, 313], '(0.28': [292], '0.10).': [294], 'In': [295, 415, 486], 'groups': [300, 333], 'all': [301, 324, 360], 'tumors': [302, 317], 'progressing': [304], 'at': [305], '6': [306], 'weeks,': [307], 'while': [308], 'there': [314], '4': [316], 'had': [319, 334], 'decreased': [320], 'volume,': [322], '11': [325], 'animals': [326], '+': [331], 'regressing': [335], 'tumors.': [336], 'growth': [339], 'inhibition': [340], 'reflected': [343], 'serum': [347], 'PSA.': [348], 'Most': [349], 'interestingly,': [350], '12-week': [352], 'follow': [353], 'analysis': [357], 'show': [358], 'three': [361], 'treatments': [362], 'resulted': [363], 'benefits': [367], 'but': [368], 'therapy': [371], 'most': [375], 'pronounced': [376, 440], 'resulting': [377], 'vs': [380], 'HR': [383], '=': [384, 388], '0.09': [385], 'P': [387], '0.0415': [389], 'no': [392], 'deaths': [393], 'observed': [394], 'group.': [398], 'No': [399], 'negative': [401], 'side': [402], 'associated': [405], 'treatment.': [409], 'Additional': [410], 'post-treatment': [411], 'analyses': [412], 'are': [413], 'underway.': [414], 'summary,': [416], 'our': [417], 'results': [418, 450], 'clearly': [419], 'indicate': [420], 'possesses': [427], 'strong': [428, 453], 'antitumor': [429], 'activity': [430], 'much': [438], 'more': [439], 'than': [441], 'inhibitory': [443], 'either': [446], 'agent': [447], 'alone.': [448], 'These': [449], 'provide': [451], 'rationale': [454], 'clinical': [456], 'testing': [457], 'androgen-directed': [464], 'strategies.': [466], 'Citation': [467], 'Format:': [468], 'Vincent': [469], 'A.': [470], 'DiPippo,': [471], 'Holly': [472], 'M.': [473], 'Nguyen,': [474], 'Lisha': [475], 'G.': [476], 'Brown,': [477], 'William': [478], 'C.': [479], 'Olson,': [480], 'Robert': [481], 'L.': [482], 'Vessella,': [483], 'Eva': [484], 'Corey.': [485], 'vivo': [487], 'cancer.': [499], '[abstract].': [500], 'In:': [501], 'Proceedings': [502], '106th': [505], 'Annual': [506], 'Meeting': [507], 'American': [510], 'Association': [511], 'Cancer': [513, 523], 'Research;': [514], '2015': [515], 'Apr': [516], '18-22;': [517], 'Philadelphia,': [518], 'PA.': [519], 'Philadelphia': [520], '(PA):': [521], 'AACR;': [522], 'Res': [524], '2015;75(15': [525], 'Suppl):Abstract': [526], 'nr': [527], '1685.': [528], 'doi:10.1158/1538-7445.AM2015-1685': [529]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2198268645', 'counts_by_year': [{'year': 2024, 'cited_by_count': 1}, {'year': 2022, 'cited_by_count': 1}, {'year': 2016, 'cited_by_count': 1}], 'updated_date': '2024-12-12T10:07:36.229211', 'created_date': '2016-06-24'}